Evaluate the Efficacy and Safety of Anti-Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta-Analysis
Author:
Affiliation:
1. Department of Neurology; The First Teaching Hospital of Jilin University; Changchun Jilin 130021 China
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference109 articles.
1. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: A double-blind, placebo-controlled study. The international gabapentin study group;Anhut;Epilepsia,1994
2. Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin paediatric study group;Appleton;Epilepsia,1999
3. Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures;Arroyo;Epilepsia,2004
4. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy;Barcs;Epilepsia,2000
5. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures;Baulac;Epilepsy Res,2010
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rufinamide, a Triazole-Derived Antiepileptic Drug, Stimulates Ca2+-Activated K+ Currents While Inhibiting Voltage-Gated Na+ Currents;International Journal of Molecular Sciences;2022-11-08
2. Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis;Brain and Behavior;2022-10-02
3. Localizing epileptic focus and assessing electrical stimulus effects on epilepsy in rats using stretchable micro electrocorticogram electrodes;Science China Materials;2022-05-12
4. Anti-convulsant Agents: Gabapentin and Pregabalin;NeuroPsychopharmacotherapy;2022
5. Drugs for patients with epilepsy and excessive daytime sleepiness;Epilepsy & Behavior;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3